Concurrent 6: Clinical Research and Epidemiology

Date: Friday 30 September 2022
Time: 16.30-18.00

Room 3

Chairs: Sara Brown (Edinburgh), Kaisa Tasanen (Oulu)

Concurrent talks are 8 minutes plus 2 minutes discussion







Association between oral corticosteroid prescribing patterns and appropriate fracture preventive care: UK and Ontario population-based cohort studies

J Matthewman,1 M Tadrous,2 K Mansfield,1 D Thiruchelvam,2 D Redelmeier,2 A Cheung,4 I Lega,2 D Prieto-Alhambra,3 L Cunliffe,2 S Langan1 and A Drucker2 1 London School of Hygiene & Tropical Medicine, London, United Kingdom, 2 Women’s College Research Institute, Toronto, ON, Canada, 3 University of Oxford, Oxford, United Kingdom and 4 University of Toronto, Toronto, ON, Canada




Dupilumab treatment shifts the microbiome towards a healthy skin flora – a TREATgermany study

J Hartmann,1 N Sander,1 I Harder,1 L Moitinho-Silva,1 R Häsler,1 E Rodriguez,1 E Haufe,2 J Schmitt,2 T Werfel3 and S Weidinger1 1 UKSH Kiel, Kiel, Germany, 2 University Hospital and medical faculty Carl Gustav Carus, Dresden, Germany and 3 Hannover Medical School, Hannover, Germany




Early life exposure to antibiotics and laxatives in relation to infantile atopic eczema

S El-Heis,1 SR Crozier,1 HM Inskip,1 NC Harvey,1 E Healy2 and KM Godfrey1 1 MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, United Kingdom and 2 Dermatopharmacology, University of Southampton, Southampton, United Kingdom




Terbinafine-resistant dermatophytosis: an emerging global health threat

G Blanchard, Y Chang, K Salamin, M Fratti, O Bontems, M Monod and E Guenova Dermatology and Venereology, CHUV, Lausanne, Switzerland




The thirteen bacterial species inversely correlated with disease activities of atopic dermatitis in human showed a biotherapeutic potential based on their suppressive effects in mice

H Kawasaki,1 K Masuda,2 J Isayama,2 Y Aoto,2 S Obata,1 A Fukushima-Nomura,1 Y Ito,1 K Tanase,1 E Kawakami3 and M Amagai1 1 Dermatology, Keio University School of Medicine, Tokyo, Japan, 2 JSR-Keio University Medical and Chemical Innovation Center, Tokyo, Japan and 3 Advanced Data Science Project, RIKEN, Yokohama, Japan




Microdissection-based spatial transcriptomics unraveled orchestrated epidermal-dermal interactions in atopic dermatitis

T Miyai,1,2 H Kawasaki,1,2 M Hosokawa,3 H Matsunaga,4 A Fukushima-Nomura,2 A Sekita,1 M Amagai,2 H Takeyama3 and H Koseki1 1 Lab for Developmental Genetics, RIKEN IMS, Yokohama, Japan, 2 Dept. of Dermatology, Keio Univ. School of Med., Tokyo, Japan, 3 Dept. of Life Sci. and Med. Biosci., Waseda Univ., Tokyo, Japan and 4 Res. Org. Nano Life Innov., Waseda Univ., Tokyo, Japan




Personalised predictions of AD severity dynamics and treatment recommendations using a Bayesian machine learning approach

G Hurault and RJ Tanaka Imperial College London, London, United Kingdom




Investigation of gene-environment interactions in atopic eczema using data from 200,000 European cohort participants

M Standl,2 A Budu-Aggrey,3 S Langan,4 L Paternoster3 and SJ Brown1 1 Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, United Kingdom, 2 Institute of Epidemiology, Helmholtz Zentrum München, Munich, Germany, 3 MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom and 4 London School of Hygiene and Tropical Medicine, London, United Kingdom